472 related articles for article (PubMed ID: 22615115)
1. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
[TBL] [Abstract][Full Text] [Related]
2. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
Yin H; Gui Y; Zheng XL
J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
[TBL] [Abstract][Full Text] [Related]
3. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
[TBL] [Abstract][Full Text] [Related]
4. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism.
Wamhoff BR; Bowles DK; McDonald OG; Sinha S; Somlyo AP; Somlyo AV; Owens GK
Circ Res; 2004 Aug; 95(4):406-14. PubMed ID: 15256479
[TBL] [Abstract][Full Text] [Related]
5. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin.
Muñoz-García B; Martín-Ventura JL; Martínez E; Sánchez S; Hernández G; Ortega L; Ortiz A; Egido J; Blanco-Colio LM
Stroke; 2006 Aug; 37(8):2044-53. PubMed ID: 16809572
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
[TBL] [Abstract][Full Text] [Related]
8. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells.
Wada H; Abe M; Ono K; Morimoto T; Kawamura T; Takaya T; Satoh N; Fujita M; Kita T; Shimatsu A; Hasegawa K
Biochem Biophys Res Commun; 2008 Oct; 374(4):731-6. PubMed ID: 18671946
[TBL] [Abstract][Full Text] [Related]
9. Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension.
Zhou N; Lee JJ; Stoll S; Ma B; Costa KD; Qiu H
Cell Physiol Biochem; 2017; 44(2):701-715. PubMed ID: 29169155
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells.
Jiang Y; Yin H; Zheng XL
J Cell Physiol; 2010 Nov; 225(2):506-11. PubMed ID: 20458751
[TBL] [Abstract][Full Text] [Related]
11. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
Chiu CZ; Wang BW; Shyu KG
Eur J Clin Invest; 2012 May; 42(5):564-71. PubMed ID: 22129233
[TBL] [Abstract][Full Text] [Related]
12. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
Hinson JS; Medlin MD; Lockman K; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1170-80. PubMed ID: 16997888
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
14. Curcumin enhances vascular contractility via induction of myocardin in mouse smooth muscle cells.
Sun SW; Tong WJ; Guo ZF; Tuo QH; Lei XY; Zhang CP; Liao DF; Chen JX
Acta Pharmacol Sin; 2017 Oct; 38(10):1329-1339. PubMed ID: 28504250
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells.
Yin H; Jiang Y; Li H; Li J; Gui Y; Zheng XL
J Cell Physiol; 2011 Jul; 226(7):1897-906. PubMed ID: 21506120
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products interfere with gastric smooth muscle contractile marker expression via the AGE/RAGE/NF-κB pathway.
Yu T; Zheng Y; Wang Y; Xiong W; Lin L
Exp Mol Pathol; 2017 Feb; 102(1):7-14. PubMed ID: 27939576
[TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
18. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
Pagiatakis C; Gordon JW; Ehyai S; McDermott JC
J Biol Chem; 2012 Mar; 287(11):8361-70. PubMed ID: 22275376
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation.
Alp Yildirim Fİ; Kaleli Durman D; Aypar E; Ark M; Özdemir O; Uydeş Doğan BS
Fundam Clin Pharmacol; 2016 Apr; 30(2):96-106. PubMed ID: 26610064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
